These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 19034331)

  • 1. Serum fibrinogen levels are an independent predictor of mortality in patients with chronic kidney disease (CKD) stages 3 and 4.
    Goicoechea M; de Vinuesa SG; Gómez-Campderá F; Aragoncillo I; Verdalles U; Mosse A; Luño J
    Kidney Int Suppl; 2008 Dec; (111):S67-70. PubMed ID: 19034331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive cardiovascular risk factors in patients with chronic kidney disease (CKD).
    Goicoechea M; de Vinuesa SG; Gómez-Campderá F; Luño J
    Kidney Int Suppl; 2005 Jan; (93):S35-8. PubMed ID: 15613066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease.
    Menon V; Greene T; Wang X; Pereira AA; Marcovina SM; Beck GJ; Kusek JW; Collins AJ; Levey AS; Sarnak MJ
    Kidney Int; 2005 Aug; 68(2):766-72. PubMed ID: 16014054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of cardiac troponin T levels in chronic kidney disease patients: predictive value for cardiovascular risk.
    Goicoechea M; Garca de Vinuesa S; Gómez-Campderá F; Gutierrez MJ; Blanco P; Amann R; Luño J
    Am J Kidney Dis; 2004 May; 43(5):846-53. PubMed ID: 15112175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The circulating soluble TRAIL is a negative marker for inflammation inversely associated with the mortality risk in chronic kidney disease patients.
    Liabeuf S; Barreto DV; Barreto FC; Chasseraud M; Brazier M; Choukroun G; Kamel S; Massy ZA
    Nephrol Dial Transplant; 2010 Aug; 25(8):2596-602. PubMed ID: 20190248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-reactive protein and low albumin are predictors of morbidity and cardiovascular events in chronic kidney disease (CKD) 3-5 patients.
    Soriano S; González L; Martín-Malo A; Rodríguez M; Aljama P
    Clin Nephrol; 2007 Jun; 67(6):352-7. PubMed ID: 17598370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammation, hemostasis, and the risk of kidney function decline in the Atherosclerosis Risk in Communities (ARIC) Study.
    Bash LD; Erlinger TP; Coresh J; Marsh-Manzi J; Folsom AR; Astor BC
    Am J Kidney Dis; 2009 Apr; 53(4):596-605. PubMed ID: 19110358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of Soluble CD14 and Endotoxin with Mortality, Cardiovascular Disease, and Progression of Kidney Disease among Patients with CKD.
    Poesen R; Ramezani A; Claes K; Augustijns P; Kuypers D; Barrows IR; Muralidharan J; Evenepoel P; Meijers B; Raj DS
    Clin J Am Soc Nephrol; 2015 Sep; 10(9):1525-33. PubMed ID: 26153127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of laser Doppler flowmetry tests, serum angiopoietin-2, asymmetric and symmetric dimethylarginine to predict outcome in chronic kidney disease.
    Nemcsik J; Cseprekál O; Egresits J; Kielstein J; Kümpers P; Lukasz A; Tabák Á; Marton A; Németh ZK; Járai Z; Godina G; Sallai L; Farkas K; Kiss I; Tislér A
    J Hypertens; 2017 May; 35(5):1109-1118. PubMed ID: 28106663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of synergistic effects of metabolic syndrome and plasma fibrinogen on coronary events and mortality in moderate CKD.
    Ramkumar N; Murtaugh MA; Cheung AK; Beddhu S
    Am J Kidney Dis; 2007 Mar; 49(3):356-64. PubMed ID: 17336696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Predictive value of fibrinogen and high-sensitivity C-reaction protein for cardiovascular events in patients with stable coronary artery disease].
    Huang W; Chen QW; Lei H; Deng W; Ke DZ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Aug; 34(8):718-21. PubMed ID: 17081398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mild depression versus C-reactive protein as a predictor of cardiovascular death: a three year follow-up of patients with stable coronary artery disease.
    Rallidis LS; Varounis C; Sourides V; Charalampopoulos A; Kotakos C; Liakos G; Dagres N; Apostolou T; Anastasiou-Nana M
    Curr Med Res Opin; 2011 Jul; 27(7):1407-13. PubMed ID: 21568834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of cardiac biomarkers for death in a non-dialysis chronic kidney disease population.
    Vickery S; Webb MC; Price CP; John RI; Abbas NA; Lamb EJ
    Nephrol Dial Transplant; 2008 Nov; 23(11):3546-53. PubMed ID: 18562472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seventeen year risk of all-cause and cause-specific mortality associated with C-reactive protein, fibrinogen and leukocyte count in men and women: the EPIC-Norfolk study.
    Ahmadi-Abhari S; Luben RN; Wareham NJ; Khaw KT
    Eur J Epidemiol; 2013 Jul; 28(7):541-50. PubMed ID: 23821244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients.
    Zimmermann J; Herrlinger S; Pruy A; Metzger T; Wanner C
    Kidney Int; 1999 Feb; 55(2):648-58. PubMed ID: 9987089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.
    Kistorp C; Raymond I; Pedersen F; Gustafsson F; Faber J; Hildebrandt P
    JAMA; 2005 Apr; 293(13):1609-16. PubMed ID: 15811980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study.
    Panichi V; Rizza GM; Paoletti S; Bigazzi R; Aloisi M; Barsotti G; Rindi P; Donati G; Antonelli A; Panicucci E; Tripepi G; Tetta C; Palla R;
    Nephrol Dial Transplant; 2008 Jul; 23(7):2337-43. PubMed ID: 18305316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain natriuretic peptide between traditional and nontraditional risk factors in hemodialysis patients: analysis of cardiovascular mortality in a two-year follow-up.
    Selim G; Stojceva-Taneva O; Spasovski G; Georgievska-Ismail L; Zafirovska-Ivanovska B; Gelev S; Dzekova P; Trajcevska L; Trojacanec-Piponska S; Sikole A
    Nephron Clin Pract; 2011; 119(2):c162-70. PubMed ID: 21757955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the long-term prognostic value of cystatin C to other indicators of renal function, markers of inflammation and systolic dysfunction among patients with acute coronary syndrome.
    Kilic T; Oner G; Ural E; Yumuk Z; Sahin T; Bildirici U; Acar E; Celikyurt U; Kozdag G; Ural D
    Atherosclerosis; 2009 Dec; 207(2):552-8. PubMed ID: 19523634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fetuin-A is not associated with mortality in chronic kidney disease.
    Ix JH; Shlipak MG; Sarnak MJ; Beck GJ; Greene T; Wang X; Kusek JW; Collins AJ; Levey AS; Menon V
    Kidney Int; 2007 Dec; 72(11):1394-9. PubMed ID: 17882149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.